ELISA – Products

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

Revvity, Inc. (NYSE: RVTY), announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.

BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow.

Stem cells can self-renew and differentiate, with potential for treating diseases like cancer and heart disease. Cytokines aid in this process. Sino Biological provides recombinant cytokines and research reagents.

BIOHIT is excited to announce an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests.

This application note explores how the combination of advanced ion mobility technology, fragmentation processes and sensitive detection enable the identification of low-abundance peptides, metabolites and lipids in complex biological samples.

Explore our new AAV Titer ELISA and AAV Antibody Assay Kits, designed for exceptional specificity, sensitivity, and accuracy to elevate your gene therapy research.

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits for quantitative analysis.

The Thermo Scientific™ Varioskan™ ALF is a fast, flexible, and easy-to-use entry-level multimode microplate reader